Aptamedica

Warszawa, Poland

The startup is engaged in the development of a versatile and small device for bedside biochemical diagnosis of a patient's blood, innovating with the ability to monitor the concentration of a selected substance in real time. Depending on the disposable measuring tip chosen, we can determine the concentration of a given substance instantly - we initially plan to implement tests for the determination of antibiotics (vancomycin, gentamicin) and inflammatory markers (procalcitonin). Our technology in the use of Point-Of-Care will enable rapid diagnosis, which is crucial in the treatment of serious diseases. Timely response has a significant impact on the effectiveness of therapy, especially for diseases such as sepsis. Access to our cutting-edge technology will facilitate the work of healthcare providers, contributing to faster test results and personalized therapy.